Savient Pharmaceuticals Inc – Savient Pharmaceuticals, Inc. One Tower Center East Brunswick, New Jersey 08816 (August 9th, 2004)
It is our mutual understanding that during the term of the Employment Letter you will continue to service as Acting Chief Financial Office (CFO) until such time as a replacement CFO commences employment with Savient Pharmaceuticals, Inc. At such time, you will transfer to the position of Chief Sarbanes Implementation Officer (CSIO) to lead the Companys implementation of Section 404 of the Sarbanes-Oxley Act. In the position of CSIO you will report to the Companys Chief Executive Officer. The Termination section of the Employment Letter is hereby modified to reflect the Companys contractual commitment to extend your employment through December 31, 2004 and if the Company terminates your employment prior to that date, unless for cause, your compensation will be paid through December 31, 2004. All other terms and conditions of the Employment Letter will remain in effect.
Savient Pharmaceuticals Inc – Employment Letter (March 12th, 2004)